Paclitaxel and Glomerulonephritis - a phase IV clinical study of FDA data

Summary:

Glomerulonephritis is reported as a side effect among people who take Paclitaxel (paclitaxel), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Carboplatin, and have Squamous cell carcinoma of the cervix.

The phase IV clinical study analyzes which people have Glomerulonephritis when taking Paclitaxel. It is created by eHealthMe based on reports of 85,850 people who have side effects when taking Paclitaxel from the FDA, and is updated regularly.

What is Paclitaxel?

Paclitaxel has active ingredients of paclitaxel. It is often used in breast cancer. eHealthMe is studying from 85,928 Paclitaxel users. Check the latest studies of Paclitaxel.

What is Glomerulonephritis?

Glomerulonephritis (a group of conditions that affect parts of the kidneys called glomeruli) is found to be associated with 307 drugs and 446 conditions by eHealthMe. Check the latest studies of Glomerulonephritis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 31, 2026

85,850 people reported to have side effects when taking Paclitaxel.
Among them, 28 people (0.03%) have Glomerulonephritis.

Could Paclitaxel cause Glomerulonephritis?

Among these 28 people:

How long have people been on Paclitaxel when they have Glomerulonephritis? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 100 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Glomerulonephritis when taking Paclitaxel? *

  • female: 82.61 %
  • male: 17.39 %

What is the age of people who have Glomerulonephritis when taking Paclitaxel? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 4.35 %
  • 30-39: 0.0 %
  • 40-49: 21.74 %
  • 50-59: 4.35 %
  • 60+: 69.57 %

What are other drugs people take besides Paclitaxel? *

  1. Carboplatin: 11 people, 39.29%
  2. Amoxicillin: 5 people, 17.86%
  3. Ciprofloxacin: 5 people, 17.86%
  4. Prednisone: 4 people, 14.29%
  5. Piperacillin And Tazobactam: 4 people, 14.29%
  6. Methylprednisolone: 4 people, 14.29%
  7. Dexamethasone: 4 people, 14.29%
  8. Cyclophosphamide: 4 people, 14.29%
  9. Amlodipine: 3 people, 10.71%
  10. Fentanyl: 2 people, 7.14%

What are other side effects people have besides Glomerulonephritis? *

  1. Nephrotic Syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema): 9 people, 32.14%
  2. Renal Impairment (severely reduced kidney function): 6 people, 21.43%
  3. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 4 people, 14.29%
  4. Fluid Intake Reduced: 4 people, 14.29%
  5. Flank Pain (a distressing sensation experienced around the lower back and the upper abdomen): 4 people, 14.29%
  6. Fever: 4 people, 14.29%
  7. Drug Ineffective: 3 people, 10.71%
  8. Acute Kidney Failure: 3 people, 10.71%
  9. Renal Tubular Disorder (disease of kidney tubules): 3 people, 10.71%
  10. Encephalopathy (functioning of the brain is affected by some agent or condition): 2 people, 7.14%

What are the existing conditions these people have? *

  1. Squamous Cell Carcinoma Of The Cervix (cervix cancer of a kind of epithelial cell): 9 people, 32.14%
  2. Metastatic Squamous Cell Carcinoma (cancer of squamous cells spreads to other part): 3 people, 10.71%
  3. Kidney Infection (Pyelonephritis): 3 people, 10.71%
  4. Breast Cancer Female: 2 people, 7.14%
  5. Gastric Cancer (stomach cancer): 2 people, 7.14%
  6. Klebsiella Sepsis (klebsiella causes a potentially fatal whole-body inflammation): 1 person, 3.57%
  7. Breast Cancer Metastatic: 1 person, 3.57%
  8. Cough: 1 person, 3.57%
  9. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 3.57%
  10. Fever: 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Paclitaxel and have Glomerulonephritis?

- Check whether Glomerulonephritis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Paclitaxel:

Glomerulonephritis treatments and more:

How severe was Glomerulonephritis and when was it recovered:

Expand to all the drugs that have ingredients of paclitaxel:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Paclitaxel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Glomerulonephritis:

Browse all the conditions that are associated with Glomerulonephritis:


How the study uses the data?

The study uses data from the FDA. It is based on paclitaxel (the active ingredients of Paclitaxel) and Paclitaxel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: